Utah Medical Products (UTMD) Non-Current Deferred Tax Liability (2010 - 2026)
Utah Medical Products (UTMD) posted quarterly Non-Current Deferred Tax Liability of $114000.0 for Q4 2025, down 81.09% year-over-year from $603000.0 in Q4 2024, and down 54.03% quarter-over-quarter from $248000.0 in Q3 2025.
Utah Medical Products (UTMD) Non-Current Deferred Tax Liability (2010 - 2026) Analysis & Trends
Utah Medical Products' Non-Current Deferred Tax Liability history runs 16 years deep, the most recent figure standing at $114000.0 for Q4 2025.
- In Q4 2025, Non-Current Deferred Tax Liability fell 81.09% year-over-year to $114000.0; the TTM figure through Dec 2025 stood at $114000.0 (down 81.09% YoY), while the FY2025 annual figure was $114000.0, down 81.09% from the prior year.
- Non-Current Deferred Tax Liability for Q4 2025 stood at $114000.0, down from $248000.0 in the prior quarter.
- The five-year high for Non-Current Deferred Tax Liability was $2.1 million in Q4 2022, with the low at $114000.0 in Q4 2025.
- The 5-year median for Non-Current Deferred Tax Liability is $615500.0 (2023), against an average of $868450.0.
- The sharpest annual moves came in 2022 and 2025: Non-Current Deferred Tax Liability surged 257.54% in 2022, then plunged 81.09% in 2025.
- Utah Medical Products' Non-Current Deferred Tax Liability stood at $577000.0 in 2021, then soared by 257.54% to $2.1 million in 2022, then plunged by 30.1% to $1.4 million in 2023, then tumbled by 58.18% to $603000.0 in 2024, then slumped by 81.09% to $114000.0 in 2025.
- Business Quant data shows UTMD's Non-Current Deferred Tax Liability at $114000.0 in Q4 2025, $248000.0 in Q3 2025, and $370000.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Utah Medical Products | 227.50 Mn | 139.97 Mn | 4.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 274,000.00 |
| Jun 30, 2026 | 274,000.00 |
| Mar 31, 2026 | 294,000.00 |
| Mar 31, 2026 | 294,000.00 |
| Dec 31, 2025 | 114,000.00 |
| Dec 31, 2025 | 114,000.00 |
| Sep 30, 2025 | 248,000.00 |
| Sep 30, 2025 | 248,000.00 |
| Jun 30, 2025 | 370,000.00 |
| Jun 30, 2025 | 370,000.00 |
| Mar 31, 2025 | 385,000.00 |
| Mar 31, 2025 | 385,000.00 |
| Dec 31, 2024 | 603,000.00 |
| Dec 31, 2024 | 603,000.00 |
| Sep 30, 2024 | 286,000.00 |
| Sep 30, 2024 | 286,000.00 |
| Jun 30, 2024 | 860,000.00 |
| Jun 30, 2024 | 860,000.00 |
| Mar 31, 2024 | 256,000.00 |
| Mar 31, 2024 | 256,000.00 |